Royal Bank of Canada
ENZY

Royal Bank of Canada’s Enzymotec Ltd ENZY Stock Holding History

Royal Bank of Canada’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8
Closed – – 7008
2017
Q1 		$0 Buy
+8
New +$68 ﹤0.01% 6985
2016
Q4 		– Sell
-250
Closed -$2K – 6919
2016
Q3 		$2K Sell
250
-150
-38% -$1.2K ﹤0.01% 6233
2016
Q2 		$3K Hold
400
– – ﹤0.01% 6104
2016
Q1 		$3K Hold
400
– – ﹤0.01% 6087
2015
Q4 		$3K Hold
400
– – ﹤0.01% 6316
2015
Q3 		$3K Buy
400
+250
+167% +$2.23K ﹤0.01% 6339
2015
Q2 		$1K Sell
150
-4
-3% -$37 ﹤0.01% 6510
2015
Q1 		$1K Buy
154
+3
+2% +$21 ﹤0.01% 6035
2014
Q4 		$1K Hold
151
– – ﹤0.01% 6091
2014
Q3 		$1K Sell
151
-40
-21% -$431 ﹤0.01% 5905
2014
Q2 		$3K Buy
191
+41
+27% +$688 ﹤0.01% 5693
2014
Q1 		$3K Buy
+150
New +$3.98K ﹤0.01% 5694

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Royal Bank of Canada's ENZY Position: Q2 2017 in Review

Royal Bank of Canada sold out of Enzymotec Ltd (ENZY) in Q2 2017, closing a stake of 8 shares.

Royal Bank of Canada first reported a position in ENZY in Q1 2014 and held it in 12 quarters. The position peaked at $3K in Q2 2016. 21 funds tracked by Wall St. Rank hold ENZY as of Q2 2017.

  • Royal Bank of Canada reported no remaining Enzymotec Ltd position as of Q2 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 8 Enzymotec Ltd shares in Q2 2017.
  • Royal Bank of Canada first reported a position in Enzymotec Ltd in Q1 2014 and held it in 12 quarters.
  • Royal Bank of Canada's Enzymotec Ltd position peaked at $3K in Q2 2016.
  • 21 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2017.

Based on Royal Bank of Canada's 13F filing for Q2 2017, filed 14 Aug 2017.